Several studies pointed out DGKα involvement in cancer showing that its activity is necessary in vivo for glioblastoma and hepatocellular carcinoma progression [13], and in vitro for proliferation and survival of endometrial carcinoma [21], anaplastic large cell lymphoma [19], and melanoma [40]. The gene discussed is DGKA; the disease is hepatocellular carcinoma.